Bispecific Antibody Market to Reach $109.4 Billion, Globally, by 2032 at 34.8% CAGR: Allied Market Research
14 août 2023 12h17 HE
|
Allied Market Research
Portland, OR, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Bispecific Antibody Market by Product (Blinatumomab, Emicizumab, and Others), Application (Cancer,...
Hemlibra (Emicizumab-kxwh): A Bispecific Factor IXa- and Factor X-directed Antibody - Global Drug Insight and Market Forecasts 2017-2030
30 déc. 2020 09h08 HE
|
Research and Markets
Dublin, Dec. 30, 2020 (GLOBE NEWSWIRE) -- The "Hemlibra (Emicizumab-kxwh) - Drug Insight and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. Hemlibra - Drug...